An international team of scientists led by Sydney’s NICM Health Research Institute, Western Sydney University examined the evidence to provide a clear overview of the benefit of specific nutrient supplements – including dosage, target symptoms, safety and tolerability – across different mental disorders.
The overview of reviews, published in World Psychiatry, examined 33 meta-analyses of randomised control trials (RCTs) and data from 10,951 people with mental health disorders including depression, stress and anxiety disorders, bipolar disorder, personality disorders, schizophrenia and attention-deficit/hyperactivity disorder (ADHD).
Summary of results:
- The strongest evidence was found for omega-3 supplements (a polyunsaturated fatty acid) as an add-on treatment for major depression – reducing symptoms of depression beyond the effects of antidepressants alone.
- There was some evidence to suggest that omega-3 supplements may also have small benefits for ADHD.
- There was emerging evidence for the amino acid N-acetylcysteine as a useful adjunctive treatment in mood disorders and schizophrenia.
- Special types of folate supplements may be effective as add-on treatments for major depression and schizophrenia, however folic acid was ineffective.
- There was no strong evidence for omega-3 for schizophrenia or other mental health conditions.
- There is currently a lack of compelling evidence supporting the use of vitamins (such as E, C, or D) and minerals (zinc and magnesium) for any mental disorder.
- All nutrient supplements had good safety profiles, with no evidence of serious adverse effects or contraindications with psychiatric medications.
You can read the press release here.
You can read the open access article here.